Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. The company is headquartered in Wilmington, Massachusetts and currently employs 18,300 full-time employees. The company went IPO on 2000-06-23. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
¿Cuál es el ratio P/E de Charles River Laboratories International Inc (CRL)?
El ratio P/E de Charles River Laboratories International Inc es 1049.6465
¿Quién es el CEO de Charles River Laboratories International Inc?
Mr. James Foster es el Chairman of the Board de Charles River Laboratories International Inc, se unió a la empresa desde 1976.
¿Qué tal es el rendimiento del precio de la acción CRL?
El precio actual de CRL es de $291.45, ha 下降 un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Charles River Laboratories International Inc?
Charles River Laboratories International Inc pertenece a la industria Life Sciences Tools & Services y el sector es Health Care
¿Cuál es la capitalización bursátil de Charles River Laboratories International Inc?
La capitalización bursátil actual de Charles River Laboratories International Inc es $14.0B
¿Es Charles River Laboratories International Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 18 analistas han realizado calificaciones de análisis para Charles River Laboratories International Inc, incluyendo 7 fuerte compra, 7 compra, 8 mantener, 0 venta, y 7 fuerte venta